Phreesia, Inc. (NYSE:PHR) Receives $31.62 Consensus PT from Analysts

Phreesia, Inc. (NYSE:PHR) has been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $31.62.

A number of equities analysts recently issued reports on the company. Raymond James reaffirmed an “outperform” rating and set a $30.00 target price (up from $25.00) on shares of Phreesia in a research report on Friday, March 15th. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a report on Friday, March 15th. JMP Securities upped their price objective on shares of Phreesia from $28.00 to $30.00 and gave the company a “market outperform” rating in a research note on Thursday, March 21st. Royal Bank of Canada reissued a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a research report on Thursday, March 21st. Finally, Barclays assumed coverage on shares of Phreesia in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $29.00 price target for the company.

Phreesia Stock Performance

Shares of PHR opened at $22.62 on Tuesday. Phreesia has a 12-month low of $12.05 and a 12-month high of $34.98. The stock has a market capitalization of $1.28 billion, a P/E ratio of -8.98 and a beta of 0.92. The firm’s 50 day moving average is $24.40 and its 200-day moving average is $21.26. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.78 and a quick ratio of 1.78.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.02. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The firm had revenue of $95.00 million for the quarter, compared to analyst estimates of $93.52 million. During the same quarter in the previous year, the business posted ($0.72) earnings per share. The firm’s quarterly revenue was up 24.0% compared to the same quarter last year. Equities research analysts anticipate that Phreesia will post -1.48 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In related news, SVP Amy Beth Vanduyn sold 3,354 shares of the stock in a transaction on Monday, April 8th. The stock was sold at an average price of $22.62, for a total transaction of $75,867.48. Following the completion of the sale, the senior vice president now directly owns 123,463 shares in the company, valued at $2,792,733.06. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other Phreesia news, CEO Chaim Indig sold 12,043 shares of Phreesia stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $22.62, for a total value of $272,412.66. Following the completion of the sale, the chief executive officer now directly owns 1,225,397 shares in the company, valued at $27,718,480.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Amy Beth Vanduyn sold 3,354 shares of the stock in a transaction on Monday, April 8th. The stock was sold at an average price of $22.62, for a total transaction of $75,867.48. Following the transaction, the senior vice president now owns 123,463 shares in the company, valued at approximately $2,792,733.06. The disclosure for this sale can be found here. In the last quarter, insiders have sold 81,808 shares of company stock worth $1,884,749. 5.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Phreesia

A number of large investors have recently bought and sold shares of PHR. Brown Advisory Inc. grew its stake in Phreesia by 22.2% in the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock valued at $91,451,000 after buying an additional 716,374 shares during the last quarter. FMR LLC raised its stake in Phreesia by 8.6% during the 3rd quarter. FMR LLC now owns 7,856,551 shares of the company’s stock valued at $146,760,000 after purchasing an additional 624,456 shares during the last quarter. Rock Springs Capital Management LP boosted its holdings in Phreesia by 36.1% in the 3rd quarter. Rock Springs Capital Management LP now owns 1,776,391 shares of the company’s stock valued at $33,183,000 after purchasing an additional 471,391 shares during the period. Norges Bank acquired a new stake in Phreesia in the 4th quarter worth $8,199,000. Finally, BlackRock Inc. increased its holdings in shares of Phreesia by 5.8% during the 1st quarter. BlackRock Inc. now owns 6,359,641 shares of the company’s stock worth $167,640,000 after purchasing an additional 349,301 shares during the period. 92.10% of the stock is currently owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.